Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Environmental Pollution (Barking, Essex : 1987)|April 9, 2020
Landfill leachate treatment through the combination of genetically engineered bacteria Rhodococcus erythropolis expressing Nirs and AMO and membrane filtration processesFuliang Bai, Hui Tian, Jun Ma
Bioresource Technology|May 27, 2019
Advanced treatment of sewage by membrane bioreactor associate with genetically engineered autotrophic nitrifying bacteriaFuliang Bai, Hui Tian, Jun Ma
Journal of Environmental Management|February 21, 2025
Sustainable pollution removal and resources recovery from electroplating wastewater by coagulation, advanced oxidation coupling with bioaugmentationFuliang Bai, Hui Tian, Shuo Liu
Environmental Pollution (Barking, Essex : 1987)|December 12, 2022
Treatment of nanofiltration concentrate of landfill leachate using advanced oxidation processes incorporated with bioaugmentationFuliang Bai, Hui Tian, Chunguang Wang, et al.
Journal of Hazardous Materials|January 25, 2025
Biodegradation of polyethylene with polyethylene-group-degrading enzyme delivered by the engineered Bacillus velezensisFuliang Bai, Jie Fan, Xiangyu Zhang, et al.
Journal of Hazardous Materials|May 15, 2026
Electron‑flow‑driven synergistic mineralization of naphthalene by an S‑N‑doped biochar‑bridged engineered consortiumFuliang Bai, Chao Yang, Ze Yu, et al.
Aging|May 30, 2019
Simvastatin induces breast cancer cell death through oxidative stress up-regulating miR-140-5pFuliang Bai, Ze Yu, Xin Gao, et al.
Trends in Biotechnology|November 22, 2025
Solar-driven PHB synthesis from wastewater by engineered semiconductor-bacteria biohybridsFuliang Bai, Yuxin Wen, Shuo Liu, et al.
The Science of the Total Environment|August 5, 2023
Spatial distribution, source apportionment and potential ecological risk assessment of suspended atmosphere microplastics in different underlying surfaces in HarbinShuo Liu, Fuliang Bai, Zhiyuan Men, et al.
Immunology Letters|March 12, 2014
Genetically engineered Newcastle disease virus expressing interleukin 2 is a potential drug candidate for cancer immunotherapyFuliang Bai, Zeshan Niu, Hui Tian, et al.
Pageof 2